Lutetium-177 (Lu-177) Market is Segmented by Type (Non-carrier-added, Carrier-added), by Application (Nuclear Therapy, Others). The Lutetium-177 market is poised for significant expansion as demand ...

Lutetium-149 undergoes a rare type of radioactive decay. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Physicists in Finland have created a ...

Blue Earth Therapeutics today announced that the first patients in the UK have been administered with the investigational ...

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have opened a clinical trial that will look at whether ...

Dr Jeremie Calais reviews the VISION trial and the implications of the data in the treatment paradigm for metastatic castration-resistant prostate cancer (mCRPC). Alicia Morgans, MD: I am curious from ...

Urology consultation: MRI of a male pelvis showing the bladder and the prostate. Treatment with lutetium-177 PSMA offers overall survival similar to cabazitaxel, with lower adverse event rates and ...

“This agreement underscores the potential of our n.c.a. Lutetium-177 to provide therapeutic value to patients with hard-to-treat tumors. Through our proprietary pipeline of Targeted Radionuclide ...

At the 2021 virtual annual meeting of the American Society for Clinical Oncology (ASCO), results of the VISION trial testing the addition of Novartis AG's radiopharmaceutical lutetium-177-PSMA-617 ...

GARCHING / MUNICH, Germany and INDIANAPOLIS, July 31, 2023 (GLOBE NEWSWIRE) -- ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company and POINT Biopharma Global Inc.

At the heart of an atomic clock are, as the name suggests, atoms of a specific type. Different sorts of atoms have been used over the years to make sure these timepieces are as precise and stable as ...

A lot can happen in a second; you could meet a stranger, snap your fingers, fall in love, fall asleep, sneeze. But what is a second, really — and is it as precise as we think it is? Right now, the ...